Targeting RNA metabolism and immune sensing mechanisms to discover innovative small-molecule therapeutics for the treatment of cancer
Employees: 11-50
Total raised: $110M
Investors 1
| Date | Name | Website |
| 29.12.2021 | New Enterp... | nea.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 28.09.2024 | Series B | $50M | - |
| 22.09.2021 | - | $60M | New Enterp... |
Mentions in press and media 6
| Date | Title | Description |
| 30.09.2024 | 858 Therapeutics Secures $50 Million to Propel Cancer Drug Development | In the world of biotechnology, funding is the lifeblood that fuels innovation. Recently, 858 Therapeutics, a San Diego-based company, secured a significant boost of $50 million in Series B financing. This funding round was led by Avidity Pa... |
| 28.09.2024 | 858 Therapeutics: Drug Discovery Company Raises $50 Million (Series B) | 858 Therapeutics announced it raised $50 million in a Series B financing led by Avidity Partners. Participation came from Insight Partners, Mirae Asset Capital, and Alexandria Venture Investments, as well as existing investors Versant Ventu... |
| 27.09.2024 | 858 Therapeutics Raises $50M in Series B Financing | 858 Therapeutics, a San Diego, CA-based biotechnology and drug discovery company, raised $50M in Series B funding. The round was led by Avidity Partners with participation from Insight Partners, Mirae Asset Capital, and Alexandria Venture I... |
| 22.09.2021 | 858 Therapeutics Raises $60M in Series A Funding | 858 Therapeutics, a San Diego CA-based biotechnology and drug discovery company, raised $60M in Series A funding. The round was led by Versant Ventures, with participation from NEA, Cormorant Asset Management and Logos Capital. The company ... |
| 21.09.2021 | 858 Therapeutics Exits Stealth Mode With $60M Funding | San Diego-based 858 Therapeutics, a biotech startup focused on small molecules, has exited stealth mode and announced a $60M, Series A funding. According to the company, the funding was led by founding investor Versant Ventures, with partic... |
| - | 858 Therapeutics | “Targeting RNA metabolism and immune sensing mechanisms to discover innovative small-molecule therapeutics for the treatment of cancer” |